Olfactory Disorder: Clinical Trials

1 trial for Olfactory Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Olfactory Disorder: new trials by email Literature Review of Olfactory Disorder trials Research Report on Olfactory Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
Stellate Ganglion Block - Anosmia, Hyposmia
Phase 1 / Phase 2CompletedWashington University School of Medicine202022-09-012026-02-12

Narrower conditions

Anosmia (1)  ·  COVID-19 (1)  ·  Olfaction Disorders (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Mepivacaine (1)

Sponsors

Washington University School of Medicine (1)

Countries

United States (1)